State WA
Clinical Trials in Washington
Recruiting clinical trials with at least one study location in Washington. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington
Colorectal Cancer (8)Breast Cancer (7)Prostate Cancer (7)Malignant Solid Neoplasm (6)Acute Myeloid Leukemia (5)Melanoma (5)Non-small Cell Lung Cancer (5)Acute Lymphoblastic Leukemia (4)Ovarian Cancer (4)Hematopoietic and Lymphatic System Neoplasm (4)Mantle Cell Lymphoma (3)Mixed Phenotype Acute Leukemia (3)
NCT06491030 Phase 4
Recruiting
Post-Operative Thoracolumosacral Orthosis for PJK
Condition
Proximal Junctional Kyphosis
Enrollment
84 pts
Location
United States
Sponsor
Hospital for Special Surgery,
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT06570798 Phase 2
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune ...
Condition
Systemic Lupus Erythematosus
Enrollment
220 pts
Location
United States, Australia, Belgium
Sponsor
Amgen
NCT05050136 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixib...
Condition
Primary Biliary Cholangitis
Enrollment
260 pts
Location
United States, Argentina, Belgium
Sponsor
Mirum Pharmaceuticals, Inc.
NCT06717698 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130...
Condition
Chronic Kidney Disease
Enrollment
465 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT04028687 N/A
Recruiting
MDR - PMCF Study for Taperloc Complete Stems
Condition
Hip Arthritis
Enrollment
820 pts
Location
United States
Sponsor
Zimmer Biomet
NCT06809192 N/A
Recruiting
Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for...
Condition
Multiple Sclerosis
Enrollment
112 pts
Location
United States
Sponsor
University of Washington
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT03474029 Phase 2, Phase 3
Recruiting
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given D...
Condition
Latent Tuberculosis
Enrollment
3,400 pts
Location
United States, Australia, Canada
Sponsor
Centers for Disease Control an
NCT05765812 Phase 1, Phase 2
Recruiting
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants Wit...
Condition
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Enrollment
116 pts
Location
United States, Spain, Switzerland
Sponsor
Debiopharm International SA
NCT06039371 Phase 2
Recruiting
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castrati...
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
69 pts
Location
United States
Sponsor
University of Washington
NCT06660394 Phase 3
Recruiting
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults ...
Condition
Dravet Syndrome
Enrollment
160 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT05426200 N/A
Recruiting
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Tran...
Condition
Lung Transplant
Enrollment
230 pts
Location
United States
Sponsor
Mayo Clinic
NCT05862272 Phase 3
Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugoli...
Condition
Uterine Fibroids
Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT04712877 N/A
Recruiting
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patien...
Condition
NSCLC
Enrollment
1,000 pts
Location
United States
Sponsor
Lung Cancer Mutation Consortiu
NCT07015242 Phase 2
Recruiting
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as Fir...
Condition
Lymphoma
Enrollment
65 pts
Location
United States, France, Germany
Sponsor
Juno Therapeutics, Inc., a Bri
NCT06833073 Phase 2
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Ca...
Condition
Urinary Bladder Neoplasms
Enrollment
308 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition
Acute Liver Failure
Enrollment
163 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT02227251 Phase 2
Recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Ly...
Condition
Diffuse Large B-cell Lymphoma
Enrollment
244 pts
Location
United States, Australia, Austria
Sponsor
Karyopharm Therapeutics Inc
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.
NCT04102566 Phase 4
Recruiting
Optimizing Pain Control in Transurethral Resection of the Prostate
Condition
Pain
Enrollment
50 pts
Location
United States
Sponsor
Benaroya Research Institute
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrom...
Condition
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT02328677 N/A
Recruiting
ColoCare Study - Colorectal Cancer Cohort
Condition
Colorectal Cancer
Enrollment
5,000 pts
Location
United States, Germany
Sponsor
University of Utah